Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics.

PubWeight™: 2.32‹?› | Rank: Top 2%

🔗 View Article (PMID 15671670)

Published in Cloning Stem Cells on January 01, 2004

Authors

Irina Klimanskaya1, Jason Hipp, Kourous A Rezai, Michael West, Anthony Atala, Robert Lanza

Author Affiliations

1: Advanced Cell Technology, One Innovation Drive, Worcester, MA 01605, USA.

Articles citing this

Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci U S A (2009) 3.53

Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest Ophthalmol Vis Sci (2006) 2.74

Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One (2009) 2.54

Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells (2011) 2.26

Transcriptome analysis and molecular signature of human retinal pigment epithelium. Hum Mol Genet (2010) 2.20

Stepwise differentiation of pluripotent stem cells into retinal cells. Nat Protoc (2009) 1.88

Fibrosis and diseases of the eye. J Clin Invest (2007) 1.79

Reprogramming cellular identity for regenerative medicine. Cell (2012) 1.71

Stem cells in retinal regeneration: past, present and future. Development (2013) 1.59

Specification of neuronal and glial subtypes from human pluripotent stem cells. Cell Mol Life Sci (2011) 1.40

Human induced pluripotent stem-derived retinal pigment epithelium (RPE) cells exhibit ion transport, membrane potential, polarized vascular endothelial growth factor secretion, and gene expression pattern similar to native RPE. Stem Cells (2011) 1.39

Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay. Mol Vis (2009) 1.35

The new paradigm: retinal pigment epithelium cells generated from embryonic or induced pluripotent stem cells. Pigment Cell Melanoma Res (2010) 1.32

Rapid and efficient directed differentiation of human pluripotent stem cells into retinal pigmented epithelium. Stem Cells Transl Med (2013) 1.27

Toward the defined and xeno-free differentiation of functional human pluripotent stem cell-derived retinal pigment epithelial cells. Mol Vis (2011) 1.25

Polarized secretion of PEDF from human embryonic stem cell-derived RPE promotes retinal progenitor cell survival. Invest Ophthalmol Vis Sci (2011) 1.18

Transplantation of reprogrammed embryonic stem cells improves visual function in a mouse model for retinitis pigmentosa. Transplantation (2010) 1.17

Human RPE stem cells grown into polarized RPE monolayers on a polyester matrix are maintained after grafting into rabbit subretinal space. Stem Cell Reports (2014) 1.11

A simple and scalable process for the differentiation of retinal pigment epithelium from human pluripotent stem cells. Stem Cells Transl Med (2013) 1.09

Tissue engineering, stem cells, cloning, and parthenogenesis: new paradigms for therapy. J Exp Clin Assist Reprod (2004) 1.08

Biology and therapy of inherited retinal degenerative disease: insights from mouse models. Dis Model Mech (2015) 1.05

Effects of extracellular matrix and neighboring cells on induction of human embryonic stem cells into retinal or retinal pigment epithelial progenitors. Exp Eye Res (2008) 1.04

Developing cellular therapies for retinal degenerative diseases. Invest Ophthalmol Vis Sci (2014) 1.03

Human embryonic stem cells: derivation, culture, and differentiation: a review. Restor Neurol Neurosci (2010) 1.02

Three-dimensional neuroepithelial culture from human embryonic stem cells and its use for quantitative conversion to retinal pigment epithelium. PLoS One (2013) 1.01

Stem cell-based therapeutic applications in retinal degenerative diseases. Stem Cell Rev (2011) 1.01

Comparison of FRPE and human embryonic stem cell-derived RPE behavior on aged human Bruch's membrane. Invest Ophthalmol Vis Sci (2011) 1.01

Cell replacement and visual restoration by retinal sheet transplants. Prog Retin Eye Res (2012) 1.01

Using human induced pluripotent stem cells to treat retinal disease. Prog Retin Eye Res (2013) 1.00

Transplantation of cells from eye-like structures differentiated from embryonic stem cells in vitro and in vivo regeneration of retinal ganglion-like cells. Graefes Arch Clin Exp Ophthalmol (2007) 0.98

Stem cells as a therapeutic tool for the blind: biology and future prospects. Proc Biol Sci (2011) 0.93

Stem cell and biomaterials research in dental tissue engineering and regeneration. Dent Clin North Am (2012) 0.93

Equivalence of conventionally-derived and parthenote-derived human embryonic stem cells. PLoS One (2011) 0.92

Stemming vision loss with stem cells. J Clin Invest (2010) 0.91

Embryonic stem cell-derived microvesicles induce gene expression changes in Müller cells of the retina. PLoS One (2012) 0.90

Structure and barrier properties of human embryonic stem cell-derived retinal pigment epithelial cells are affected by extracellular matrix protein coating. Tissue Eng Part A (2014) 0.90

Plasma membrane protein polarity and trafficking in RPE cells: past, present and future. Exp Eye Res (2014) 0.89

Stem cells for retinal replacement therapy. Neurotherapeutics (2011) 0.88

ROCK Inhibition Extends Passage of Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium. Stem Cells Transl Med (2014) 0.88

Stem cell sources and therapeutic approaches for central nervous system and neural retinal disorders. Neurosurg Focus (2008) 0.87

Stem cell therapies for age-related macular degeneration: the past, present, and future. Clin Interv Aging (2015) 0.87

Retinoid uptake, processing, and secretion in human iPS-RPE support the visual cycle. Invest Ophthalmol Vis Sci (2014) 0.86

Conditional knockdown of DNA methyltransferase 1 reveals a key role of retinal pigment epithelium integrity in photoreceptor outer segment morphogenesis. Development (2013) 0.86

Ophthalmologic stem cell transplantation therapies. Regen Med (2012) 0.86

Preservation of outer retina and its synaptic connectivity following subretinal injections of human RPE cells in the Royal College of Surgeons rat. Exp Eye Res (2007) 0.85

Ectopic Mitf in the embryonic chick retina by co-transfection of β-catenin and Otx2. Invest Ophthalmol Vis Sci (2010) 0.85

Stem cell-based therapies for age-related macular degeneration: current status and prospects. Int J Clin Exp Med (2014) 0.85

Stem-cell research: Never say die. Nature (2012) 0.84

Engineering efficient retinal pigment epithelium differentiation from human pluripotent stem cells. Stem Cells Transl Med (2014) 0.84

Promises of stem cell therapy for retinal degenerative diseases. Graefes Arch Clin Exp Ophthalmol (2011) 0.84

Enhancing RPE Cell-Based Therapy Outcomes for AMD: The Role of Bruch's Membrane. Transl Vis Sci Technol (2014) 0.83

Prospectives for gene therapy of retinal degenerations. Curr Genomics (2012) 0.83

Regenerating Retinal Pigment Epithelial Cells to Cure Blindness: A Road Towards Personalized Artificial Tissue. Curr Stem Cell Rep (2015) 0.83

The similarity between human embryonic stem cell-derived epithelial cells and ameloblast-lineage cells. Int J Oral Sci (2013) 0.83

Stem cells: a new paradigm for disease modeling and developing therapies for age-related macular degeneration. J Transl Med (2013) 0.83

Efficient derivation of retinal pigment epithelium cells from stem cells. J Vis Exp (2015) 0.82

Cellular models and therapies for age-related macular degeneration. Dis Model Mech (2015) 0.82

Using Stem Cells to Model Diseases of the Outer Retina. Comput Struct Biotechnol J (2015) 0.81

Differentiation of Human Protein-Induced Pluripotent Stem Cells toward a Retinal Pigment Epithelial Cell Fate. PLoS One (2015) 0.80

RPE and neuronal differentiation of allotransplantated porcine ciliary epithelium-derived cells. Mol Vis (2011) 0.79

Efficient delivery and functional expression of transfected modified mRNA in human embryonic stem cell-derived retinal pigmented epithelial cells. J Biol Chem (2015) 0.79

A FOXM1 Dependent Mesenchymal-Epithelial Transition in Retinal Pigment Epithelium Cells. PLoS One (2015) 0.79

Efflux protein expression in human stem cell-derived retinal pigment epithelial cells. PLoS One (2012) 0.79

Xeno-Free and Defined Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells Functionally Integrate in a Large-Eyed Preclinical Model. Stem Cell Reports (2015) 0.79

iPSC-Derived Retinal Pigment Epithelium Allografts Do Not Elicit Detrimental Effects in Rats: A Follow-Up Study. Stem Cells Int (2016) 0.78

Tapping Stem Cells to Target AMD: Challenges and Prospects. J Clin Med (2015) 0.78

Performing subretinal injections in rodents to deliver retinal pigment epithelium cells in suspension. J Vis Exp (2015) 0.78

Subretinal transplantation of putative retinal pigment epithelial cells derived from human embryonic stem cells in rat retinal degeneration model. Clin Exp Reprod Med (2011) 0.77

Induced Pluripotent Stem Cells: Development in the Ophthalmologic Field. Stem Cells Int (2016) 0.77

Chapter 4 - Restoring Vision to the Blind: Stem Cells and Transplantation. Transl Vis Sci Technol (2014) 0.77

Real-time quantitative monitoring of hiPSC-based model of macular degeneration on Electric Cell-substrate Impedance Sensing microelectrodes. Biosens Bioelectron (2015) 0.77

Generation and clonal isolation of retinal stem cells from human embryonic stem cells. Eur J Neurosci (2012) 0.77

A Subsequent Human Neural Progenitor Transplant into the Degenerate Retina Does Not Compromise Initial Graft Survival or Therapeutic Efficacy. Transl Vis Sci Technol (2015) 0.76

Induced Pluripotent Stem Cells and Outer Retinal Disease. Stem Cells Int (2016) 0.76

Enhanced functional integration of human photoreceptor precursors into human and rodent retina in an ex vivo retinal explant model system. Tissue Eng Part A (2015) 0.76

Looking into the future: Using induced pluripotent stem cells to build two and three dimensional ocular tissue for cell therapy and disease modeling. Brain Res (2015) 0.76

Retinal pigment epithelium differentiation of stem cells: current status and challenges. Crit Rev Biomed Eng (2009) 0.76

Derivation, culture and retinal pigment epithelial differentiation of human embryonic stem cells using human fibroblast feeder cells. J Assist Reprod Genet (2012) 0.76

The Silk-protein Sericin Induces Rapid Melanization of Cultured Primary Human Retinal Pigment Epithelial Cells by Activating the NF-κB Pathway. Sci Rep (2016) 0.75

Transplantation of reprogrammed embryonic stem cells improves visual function in a mouse model for Retinitis Pigmentosa: Transplantation 2010 April 27;89 (8): 911-919. Ann Neurosci (2010) 0.75

Identity of pigmented subretinal cells in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2016) 0.75

Distinct and Shared Determinants of Cardiomyocyte Contractility in Multi-Lineage Competent Ethnically Diverse Human iPSCs. Sci Rep (2016) 0.75

Generation of retinal pigmented epithelium from iPSCs derived from the conjunctiva of donors with and without age related macular degeneration. PLoS One (2017) 0.75

Stem cell therapies for retinal diseases: recapitulating development to replace degenerated cells. Development (2017) 0.75

Targeting the cAMP and Transforming Growth Factor-β Pathway Increases Proliferation to Promote Re-Epithelialization of Human Stem Cell-Derived Retinal Pigment Epithelium. Stem Cells Transl Med (2016) 0.75

Molecular characterisation of stromal populations derived from human embryonic stem cells: Similarities to immortalised bone marrow derived stromal stem cells. Bone Rep (2015) 0.75

Development of gene and stem cell therapy for ocular neurodegeneration. Int J Ophthalmol (2015) 0.75

Assessment of Safety and Functional Efficacy of Stem Cell-Based Therapeutic Approaches Using Retinal Degenerative Animal Models. Stem Cells Int (2017) 0.75

Strategies for retinal cell generation from human pluripotent stem cells. Stem Cell Investig (2017) 0.75

Stem Cell Derived Retinal Pigment Epithelium: The Role of Pigmentation as Maturation Marker and Gene Expression Profile Comparison with Human Endogenous Retinal Pigment Epithelium. Stem Cell Rev (2017) 0.75

Deriving, regenerating, and engineering CNS tissues using human pluripotent stem cells. Curr Opin Biotechnol (2017) 0.75

Articles by these authors

Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell (2009) 10.52

Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol (2007) 9.67

Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet (2012) 7.70

Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. Lancet (2011) 3.95

Application of genome-wide expression analysis to human health and disease. Proc Natl Acad Sci U S A (2005) 3.49

Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells (2010) 3.48

Human embryonic stem cell lines derived from single blastomeres. Nature (2006) 3.12

Human embryonic stem cell lines generated without embryo destruction. Cell Stem Cell (2008) 3.11

Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood (2008) 3.01

Inflammation and the Host Response to Injury, a Large-Scale Collaborative Project: patient-oriented research core--standard operating procedures for clinical care. II. Guidelines for prevention, diagnosis and treatment of ventilator-associated pneumonia (VAP) in the trauma patient. J Trauma (2006) 2.57

Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells (2009) 2.56

Engineering complex tissues. Tissue Eng (2006) 2.53

Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells (2008) 2.29

Carbon nanotube applications for tissue engineering. Biomaterials (2006) 2.25

Human embryonic stem cells derived without feeder cells. Lancet (2005) 2.24

Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. J Clin Invest (2011) 2.23

Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells (2006) 2.23

Culture and behaviour in the English National Health Service: overview of lessons from a large multimethod study. BMJ Qual Saf (2013) 2.23

Anterior urethral valves and diverticula in children: a result of ruptured Cowper's duct cyst? BJU Int (2004) 2.19

The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology (2011) 2.09

Generation of functional hemangioblasts from human embryonic stem cells. Nat Methods (2007) 2.06

Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat. J Mol Cell Cardiol (2006) 1.99

Generation of histocompatible tissues using nuclear transplantation. Nat Biotechnol (2002) 1.97

Platelet bioreactor-on-a-chip. Blood (2014) 1.87

Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres. Nature (2005) 1.86

Inflammation and the Host Response to Injury, a large-scale collaborative project: patient-oriented research core--standard operating procedures for clinical care. III. Guidelines for shock resuscitation. J Trauma (2006) 1.78

Antiangiogenic properties of gold nanoparticles. Clin Cancer Res (2005) 1.78

Controlled fabrication of a biological vascular substitute. Biomaterials (2005) 1.76

Inflammation and the Host Response to Injury, a large-scale collaborative project: Patient-Oriented Research Core--standard operating procedures for clinical care. I. Guidelines for mechanical ventilation of the trauma patient. J Trauma (2005) 1.73

Cell-seeded tubularized scaffolds for reconstruction of long urethral defects: a preclinical study. Eur Urol (2012) 1.69

Tissue engineering, stem cells, and cloning: opportunities for regenerative medicine. J Am Soc Nephrol (2004) 1.68

Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome. Cancer Res (2009) 1.58

Implantation of autologous urine derived stem cells expressing vascular endothelial growth factor for potential use in genitourinary reconstruction. J Urol (2011) 1.56

Decellularization methods of porcine kidneys for whole organ engineering using a high-throughput system. Biomaterials (2012) 1.55

Urine derived cells are a potential source for urological tissue reconstruction. J Urol (2008) 1.54

Bioengineered vascular access maintains structural integrity in response to arteriovenous flow and repeated needle puncture. J Vasc Surg (2012) 1.52

Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice. Cell Res (2011) 1.48

The influence of electrospun aligned poly(epsilon-caprolactone)/collagen nanofiber meshes on the formation of self-aligned skeletal muscle myotubes. Biomaterials (2008) 1.47

Whole organ decellularization - a tool for bioscaffold fabrication and organ bioengineering. Conf Proc IEEE Eng Med Biol Soc (2009) 1.47

The in vivo stability of electrospun polycaprolactone-collagen scaffolds in vascular reconstruction. Biomaterials (2008) 1.46

Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells (2008) 1.46

Multipotential differentiation of human urine-derived stem cells: potential for therapeutic applications in urology. Stem Cells (2013) 1.46

Engineered multilayer ovarian tissue that secretes sex steroids and peptide hormones in response to gonadotropins. Biomaterials (2012) 1.45

Randomized comparative study between buccal mucosal and acellular bladder matrix grafts in complex anterior urethral strictures. J Urol (2008) 1.45

Production and implantation of renal extracellular matrix scaffolds from porcine kidneys as a platform for renal bioengineering investigations. Ann Surg (2012) 1.45

Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS One (2010) 1.44

Chondrogenic differentiation of amniotic fluid-derived stem cells. J Mol Histol (2007) 1.44

Principals of neovascularization for tissue engineering. Mol Aspects Med (2002) 1.44

Reprogramming of human somatic cells using human and animal oocytes. Cloning Stem Cells (2009) 1.40

Posttraumatic hernias: historical overview and review of the literature. Am Surg (2007) 1.38

Derive and conquer: sourcing and differentiating stem cells for therapeutic applications. Nat Rev Drug Discov (2008) 1.38

Development of a composite vascular scaffolding system that withstands physiological vascular conditions. Biomaterials (2008) 1.35

Hybrid printing of mechanically and biologically improved constructs for cartilage tissue engineering applications. Biofabrication (2012) 1.34

Regenerative medicine as applied to solid organ transplantation: current status and future challenges. Transpl Int (2010) 1.33

Derivation of human embryonic stem cells from single blastomeres. Nat Protoc (2007) 1.32

Functional and biological determinants affecting the duration of action and efficacy of anti-(+)-methamphetamine monoclonal antibodies in rats. Vaccine (2009) 1.31

Stretch and growth: the molecular and physiologic influences of tissue expansion. Plast Reconstr Surg (2002) 1.30

Human urine-derived stem cells seeded in a modified 3D porous small intestinal submucosa scaffold for urethral tissue engineering. Biomaterials (2010) 1.30

Amniotic fluid and placental stem cells. Methods Enzymol (2006) 1.30

Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir. Antiviral Res (2002) 1.29

Papillomavirus E1 proteins: form, function, and features. Virus Genes (2002) 1.29

Bilayered scaffold for engineering cellularized blood vessels. Biomaterials (2010) 1.29

Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. J Urol (2007) 1.28

Urethral stricture repair with an off-the-shelf collagen matrix. J Urol (2003) 1.26

Mesenchymal stem cells and adipogenesis in hemangioma involution. Stem Cells (2006) 1.25

Differentiation of human bone marrow mesenchymal stem cells into bladder cells: potential for urological tissue engineering. Tissue Eng Part A (2010) 1.25

Oxygen generating scaffolds for enhancing engineered tissue survival. Biomaterials (2008) 1.24

Urethral replacement using cell seeded tubularized collagen matrices. J Urol (2002) 1.24

Identification and characterization of bioactive factors in bladder submucosa matrix. Biomaterials (2007) 1.24

The impact of leadership and quality climate on hospital performance. Int J Qual Health Care (2008) 1.23

A rat decellularized small bowel scaffold that preserves villus-crypt architecture for intestinal regeneration. Biomaterials (2012) 1.21

Characterization of urine-derived stem cells obtained from upper urinary tract for use in cell-based urological tissue engineering. Tissue Eng Part A (2011) 1.21

Tissue-specific extracellular matrix coatings for the promotion of cell proliferation and maintenance of cell phenotype. Biomaterials (2009) 1.21

Cell cycle checkpoint function in bladder cancer. J Natl Cancer Inst (2003) 1.21

Complex heterogeneous tissue constructs containing multiple cell types prepared by inkjet printing technology. Biomaterials (2012) 1.21

Inflammation and the host response to injury a large-scale collaborative project: patient-oriented research core standard operating procedure for clinical care X. Guidelines for venous thromboembolism prophylaxis in the trauma patient. J Trauma (2008) 1.20

Lithospheric structure of the Rio Grande rift. Nature (2005) 1.20

Tubularized urethral replacement with unseeded matrices: what is the maximum distance for normal tissue regeneration? World J Urol (2008) 1.20

In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo. Blood (2002) 1.19

Sources of stem cells for regenerative medicine. Stem Cell Rev (2008) 1.17

Oxygen producing biomaterials for tissue regeneration. Biomaterials (2007) 1.16

Myogenic differentiation of human bone marrow mesenchymal stem cells on a 3D nano fibrous scaffold for bladder tissue engineering. Biomaterials (2009) 1.16

Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN). Nephrol Dial Transplant (2009) 1.15

Regenerative medicine and organ transplantation: past, present, and future. Transplantation (2011) 1.14

Testicular volume: comparison of orchidometer and US measurements in dogs. Radiology (2002) 1.13

Human amniotic fluid stem cell preconditioning improves their regenerative potential. Stem Cells Dev (2011) 1.12

In vitro evaluation of electrospun nanofiber scaffolds for vascular graft application. J Biomed Mater Res A (2007) 1.12

Engineering functional bladder tissues. J Tissue Eng Regen Med (2012) 1.10

Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties. Stem Cells Dev (2014) 1.10

Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol Ther (2012) 1.10

Tissue-engineered conduit using urine-derived stem cells seeded bacterial cellulose polymer in urinary reconstruction and diversion. Biomaterials (2010) 1.08

Tissue engineering, stem cells, cloning, and parthenogenesis: new paradigms for therapy. J Exp Clin Assist Reprod (2004) 1.08

Engineering of blood vessels from acellular collagen matrices coated with human endothelial cells. Tissue Eng (2006) 1.07

Western Trauma Association critical decisions in trauma: nonoperative management of adult blunt hepatic trauma. J Trauma (2009) 1.07

Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells. Cancer Res (2003) 1.06

Propagation, expansion, and multilineage differentiation of human somatic stem cells from dermal progenitors. Stem Cells Dev (2005) 1.05

Cyclic mechanical preconditioning improves engineered muscle contraction. Tissue Eng Part A (2008) 1.04

Tissue engineering a complete vaginal replacement from a small biopsy of autologous tissue. Transplantation (2008) 1.04

A novel use of centrifugal force for cell seeding into porous scaffolds. Biomaterials (2004) 1.04